{"organizations": [], "uuid": "a840b05f9e8c9f46c7b925e74177c9fa9cee9a87", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-jaguar-health-says-unit-napo-pharm/brief-jaguar-health-says-unit-napo-pharmaceuticals-signs-deal-with-transition-patient-services-to-establish-nationwide-pilot-mytesi-direct-program-idUSFWN1QK0R9", "country": "US", "domain_rank": 408, "title": "BRIEF-Jaguar Health Says Unit Napo Pharmaceuticals Signs Deal With Transition Patient Services To Establish Nationwide Pilot \"Mytesi Direct\" Program", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-02T16:12:00.000+02:00", "replies_count": 0, "uuid": "a840b05f9e8c9f46c7b925e74177c9fa9cee9a87"}, "author": "", "url": "https://www.reuters.com/article/brief-jaguar-health-says-unit-napo-pharm/brief-jaguar-health-says-unit-napo-pharmaceuticals-signs-deal-with-transition-patient-services-to-establish-nationwide-pilot-mytesi-direct-program-idUSFWN1QK0R9", "ord_in_thread": 0, "title": "BRIEF-Jaguar Health Says Unit Napo Pharmaceuticals Signs Deal With Transition Patient Services To Establish Nationwide Pilot \"Mytesi Direct\" Program", "locations": [], "entities": {"persons": [], "locations": [{"name": "mytesi", "sentiment": "none"}], "organizations": [{"name": "brief-jaguar health says unit napo pharm", "sentiment": "neutral"}, {"name": "jaguar health inc", "sentiment": "none"}, {"name": "napo", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News March 2, 2018 / 2:14 PM / in 24 minutes BRIEF-Jaguar Health Says Unit Napo Pharmaceuticals Signs Deal With Transition Patient Services To Establish Nationwide Pilot \"Mytesi Direct\" Program Reuters Staff 1 Min Read March 2 (Reuters) - Jaguar Health Inc: * JAGUAR HEALTH - UNIT NAPO PHARMACEUTICALS SIGNS DEAL WITH TRANSITION PATIENT SERVICES TO ESTABLISH NATIONWIDE PILOT“MYTESI DIRECT” PROGRAM * JAGUAR HEALTH - UNDER DEAL TERMS, TRANSITION PATIENT SERVICES WILL OPERATE NATIONWIDE PILOT PROGRAM FOR MYTESI, EXPECTED TO BEGIN THIS MARCH Source text: ( bit.ly/2F6983y ) Further company coverage:", "external_links": [], "published": "2018-03-02T16:12:00.000+02:00", "crawled": "2018-03-02T16:36:17.006+02:00", "highlightTitle": ""}